The Rheumatologist
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
  • Technology
    • Electronic Health Records
    • Apps
    • Information Technology
  • Resources
    • Issue Archives
    • Events
    • Multimedia
      • Audio
      • Video
    • From the College
    • American College of Rheumatology
    • Rheumatology Research Foundation
    • Arthritis & Rheumatology
    • Arthritis Care & Research
    • Treatment Guidelines
    • Research Reviews
    • Annual Meeting
      • Abstracts
      • Meeting Reports
    • Rheumatology Image Bank
    • ACR ExamRheum
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Amgen

Articles tagged with "Amgen"

U.S. Supreme Court Declines to Hear Biologic Drug Patent Fight

December 12, 2016 • By Brendan Pierson

Big Pharma vs. Big Pharma in Court Battles over Biosimilar Drugs

October 4, 2016 • By John Miller

FDA Panel Supports Novartis Biosimilar of Etanercept

July 14, 2016 • By Reuters Staff

FDA Staff Says Amgen Biosimilar ‘Highly Similar’ to AbbVie’s Humira

July 8, 2016 • By Reuters Staff

U.S. Patent Office Rules Against Amgen Humira Challenge

January 16, 2016 • By Bill Berkrot

Amgen Files for U.S. Approval of Biosimilar

November 29, 2015 • By Bill Berkrot

Novartis Biosimilar Takes Aim at Amgen’s Enbrel

October 2, 2015 • By Michael Shields & Ben Hirschler

Novartis Launches First U.S. Biosimilar Drug at 15% Discount

September 4, 2015 • By Ben Hirschler & Michael Shields

Teriparatide to Denosumab Switch Helpful in Osteoporosis

July 16, 2015 • By David Douglas

Clinical Trials Ongoing for Brodalumab

June 5, 2015 • By Michele B. Kaufman, PharmD, BCGP

  • 1
  • 2
  • Next Page »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

ACR/ARP Meeting Abstracts

Browse and search abstracts from the ACR/ARP Annual Meetings going back to 2012.

Visit the ACR/ARP Meeting Abstracts site »

ACR/ARP Annual Meeting

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Annual Meeting site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2019 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

This site uses cookies: Find out more.